NLRC5 and clear cell renal carcinoma: NLRC5 has been identified as a regulator of the Wnt/β-catenin signaling pathway in clear cell renal carcinoma (65), and in the current study we observe increased expression of NLRC5 in FP (log2FoldChange = 3.39, padj = 3.71 × 10−12).